NOD2, an Intracellular Innate Immune Sensor Involved in Host Defense and Crohn's Disease
暂无分享,去创建一个
[1] Ricardo G. Correa,et al. Non-apoptotic role of BID in inflammation and innate immunity , 2011, Nature.
[2] J. Hugot,et al. Crohn disease--associated adherent-invasive E. coli bacteria target mouse and human Peyer's patches via long polar fimbriae. , 2011, The Journal of clinical investigation.
[3] W. Strober. Adherent-invasive E. coli in Crohn disease: bacterial "agent provocateur". , 2011, The Journal of clinical investigation.
[4] R. Bronson,et al. Nod2 Suppresses Borrelia burgdorferi Mediated Murine Lyme Arthritis and Carditis through the Induction of Tolerance , 2011, PloS one.
[5] C. Abraham,et al. Secretory mediators regulate Nod2-induced tolerance in human macrophages. , 2011, Gastroenterology.
[6] J. Asara,et al. Inhibition of RIP2's tyrosine kinase activity limits NOD2-driven cytokine responses. , 2010, Genes & development.
[7] N. Salzman,et al. Induction and rescue of Nod2-dependent Th1-driven granulomatous inflammation of the ileum , 2010, Proceedings of the National Academy of Sciences.
[8] Tomohiro Watanabe,et al. NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway. , 2010, The Journal of clinical investigation.
[9] S. Akira,et al. Pathogenic Vibrio Activate NLRP3 Inflammasome via Cytotoxins and TLR/Nucleotide-Binding Oligomerization Domain-Mediated NF-κB Signaling , 2010, The Journal of Immunology.
[10] D. Philpott,et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry , 2010, Nature Immunology.
[11] D. Jewell,et al. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation , 2010, Nature Medicine.
[12] A. Albor,et al. Nucleotide oligomerization domain-2 interacts with 2'-5'-oligoadenylate synthetase type 2 and enhances RNase-L function in THP-1 cells. , 2009, Molecular immunology.
[13] N. Warner,et al. T cell intrinsic role of Nod2 in promoting type I immunity against Toxoplasma gondii , 2009, Nature Immunology.
[14] J. Hugot,et al. Nod2 regulates the host response towards microflora by modulating T cell function and epithelial permeability in mouse Peyer's patches , 2009, Gut.
[15] R. Jenq,et al. NOD2 regulates hematopoietic cell function during graft-versus-host disease , 2009, The Journal of experimental medicine.
[16] W. Strober. The multifaceted influence of the mucosal microflora on mucosal dendritic cell responses. , 2009, Immunity.
[17] P. Scacheri,et al. ITCH K63-Ubiquitinates the NOD2 Binding Protein, RIP2, to Influence Inflammatory Signaling Pathways , 2009, Current Biology.
[18] V. Nizet,et al. NOD2 contributes to cutaneous defense against Staphylococcus aureus through α-toxin-dependent innate immune activation , 2009, Proceedings of the National Academy of Sciences.
[19] M. Reed,et al. Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide , 2009, The Journal of experimental medicine.
[20] D. Philpott,et al. A function for AAMP in Nod2-mediated NF-kappaB activation. , 2009, Molecular immunology.
[21] Kaoru Tominaga,et al. Activation of innate immune antiviral response by NOD2 , 2009, Nature Immunology.
[22] S. Fortune,et al. NOD2, RIP2 and IRF5 Play a Critical Role in the Type I Interferon Response to Mycobacterium tuberculosis , 2009, PLoS pathogens.
[23] M. Bertrand,et al. Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors NOD1 and NOD2. , 2009, Immunity.
[24] M. Kopf,et al. The Kinase Activity of Rip2 Determines Its Stability and Consequently Nod1- and Nod2-mediated Immune Responses* , 2009, The Journal of Biological Chemistry.
[25] M. Netea,et al. A Crohn's disease–associated NOD2 mutation suppresses transcription of human IL10 by inhibiting activity of the nuclear ribonucleoprotein hnRNP-A1 , 2009, Nature Immunology.
[26] D. Underhill,et al. The NOD/RIP2 Pathway Is Essential for Host Defenses Against Chlamydophila pneumoniae Lung Infection , 2009, PLoS pathogens.
[27] V. Deretic. Multiple regulatory and effector roles of autophagy in immunity. , 2009, Current opinion in immunology.
[28] R. Jenq,et al. NOD 2 regulates hematopoietic cell function during graft-versus-host disease , 2009 .
[29] D. Philpott,et al. Nod2-Dependent Th2 Polarization of Antigen-Specific Immunity1 , 2008, The Journal of Immunology.
[30] M. Behr,et al. NOD2-Deficient Mice Have Impaired Resistance to Mycobacterium tuberculosis Infection through Defective Innate and Adaptive Immunity1 , 2008, The Journal of Immunology.
[31] M. Marinaro,et al. A transient breach in the epithelial barrier leads to regulatory T-cell generation and resistance to experimental colitis. , 2008, Gastroenterology.
[32] Derek W. Abbott,et al. MEKK4 Sequesters RIP2 to Dictate NOD2 Signal Specificity , 2008, Current Biology.
[33] N. Suttorp,et al. β-PIX and Rac1 GTPase Mediate Trafficking and Negative Regulation of NOD21 , 2008, The Journal of Immunology.
[34] V. Nizet,et al. A Nod2–nalp1 Complex Mediates Caspase-1-dependent Il-1 Secretion in Response to Bacillus Anthracis Infection and Muramyl Dipeptide Nod2, a Nod-like Receptor (nlr), Is an Intracellular Sensor of Bacterial Muramyl Dipeptide (mdp) That Was Suggested to Promote Secretion of the Proinflammatory Cytokine , 2022 .
[35] Judy H. Cho,et al. The genetics and immunopathogenesis of inflammatory bowel disease , 2008, Nature Reviews Immunology.
[36] S. Akira,et al. Selective synergy in anti-inflammatory cytokine production upon cooperated signaling via TLR4 and TLR2 in murine conventional dendritic cells. , 2008, Molecular immunology.
[37] L. Joosten,et al. Crohn’s disease patients homozygous for the 3020insC NOD2 mutation have a defective NOD2/TLR4 cross‐tolerance to intestinal stimuli , 2008, Immunology.
[38] Daniel J. Klionsky,et al. Autophagy fights disease through cellular self-digestion , 2008, Nature.
[39] L. Simms,et al. Reduced α-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn’s disease , 2008, Gut.
[40] G. Núñez,et al. The cytosolic sensors Nod1 and Nod2 are critical for bacterial recognition and host defense after exposure to Toll-like receptor ligands. , 2008, Immunity.
[41] Tomohiro Watanabe,et al. Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis. , 2008, The Journal of clinical investigation.
[42] P. Lucas,et al. A critical role of RICK/RIP2 polyubiquitination in Nod‐induced NF‐κB activation , 2008 .
[43] J. Ninomiya-Tsuji,et al. TAK1 Is a Central Mediator of NOD2 Signaling in Epidermal Cells* , 2008, Journal of Biological Chemistry.
[44] L. Joosten,et al. Engagement of NOD2 has a dual effect on proIL‐1β mRNA transcription and secretion of bioactive IL‐1β , 2008, European journal of immunology.
[45] D. Portnoy,et al. Distinct TLR- and NLR-Mediated Transcriptional Responses to an Intracellular Pathogen , 2008, PLoS pathogens.
[46] P. Lucas,et al. A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation. , 2008, The EMBO journal.
[47] Judy H. Cho,et al. Chronic stimulation of Nod2 mediates tolerance to bacterial products , 2007, Proceedings of the National Academy of Sciences.
[48] Tomohiro Watanabe,et al. NOD2 transgenic mice exhibit enhanced MDP-mediated down-regulation of TLR2 responses and resistance to colitis induction. , 2007, Gastroenterology.
[49] D. Hommes,et al. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. , 2007, Immunity.
[50] Wendy S. Garrett,et al. Communicable Ulcerative Colitis Induced by T-bet Deficiency in the Innate Immune System , 2007, Cell.
[51] H. Clevers,et al. The Paneth Cell α-Defensin Deficiency of Ileal Crohn’s Disease Is Linked to Wnt/Tcf-41 , 2007, The Journal of Immunology.
[52] S. Gandotra,et al. Nucleotide-Binding Oligomerization Domain Protein 2-Deficient Mice Control Infection with Mycobacterium tuberculosis , 2007, Infection and Immunity.
[53] J. Bertin,et al. MDP‐induced interleukin‐1β processing requires Nod2 and CIAS1/NALP3 , 2007, Journal of leukocyte biology.
[54] J. Hugot,et al. CARD15/NOD2 Is Required for Peyer's Patches Homeostasis in Mice , 2007, PloS one.
[55] L. Cantley,et al. Coordinated Regulation of Toll-Like Receptor and NOD2 Signaling by K63-Linked Polyubiquitin Chains , 2007, Molecular and Cellular Biology.
[56] P. Cohen,et al. Molecular mechanisms involved in the regulation of cytokine production by muramyl dipeptide. , 2007, The Biochemical journal.
[57] D. Philpott,et al. Nod1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity. , 2007, Immunity.
[58] W. Yeh,et al. Mechanism of ASC-mediated apoptosis: Bid-dependent apoptosis in type II cells , 2007, Oncogene.
[59] P. Mannon,et al. The fundamental basis of inflammatory bowel disease. , 2007, The Journal of clinical investigation.
[60] G. Núñez,et al. RICK/RIP2 Mediates Innate Immune Responses Induced through Nod1 and Nod2 but Not TLRs1 , 2007, The Journal of Immunology.
[61] S. Vermeire,et al. NOD2/CARD15 disease associations other than Crohn's disease , 2007, Inflammatory bowel diseases.
[62] X. Qin,et al. The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens , 2007, Nature Immunology.
[63] H. Clevers,et al. The Paneth cell alpha-defensin deficiency of ileal Crohn's disease is linked to Wnt/Tcf-4. , 2007, Journal of immunology.
[64] R. Xavier,et al. Centaurin β1 Down-regulates Nucleotide-binding Oligomerization Domains 1- and 2-dependent NF-κB Activation* , 2006, Journal of Biological Chemistry.
[65] Tomohiro Watanabe,et al. Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitis. , 2006, Immunity.
[66] Tomohiro Watanabe,et al. Signalling pathways and molecular interactions of NOD1 and NOD2 , 2006, Nature Reviews Immunology.
[67] P. Lécine,et al. A Role for Erbin in the Regulation of Nod2-dependent NF-κB Signaling* , 2005, Journal of Biological Chemistry.
[68] K. Honda,et al. Negative regulation of Toll-like-receptor signaling by IRF-4. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[69] M. Netea,et al. NOD2 and Toll-Like Receptors Are Nonredundant Recognition Systems of Mycobacterium tuberculosis , 2005, PLoS pathogens.
[70] D. Philpott,et al. Synergistic stimulation of human monocytes and dendritic cells by Toll‐like receptor 4 and NOD1‐ and NOD2‐activating agonists , 2005, European journal of immunology.
[71] R. Xavier,et al. Membrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear factor–κB activation in muramyl dipeptide recognition , 2005, The Journal of cell biology.
[72] M. Chamaillard,et al. NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. , 2005, Annual review of biochemistry.
[73] Richard A. Flavell,et al. Nod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal Tract , 2005, Science.
[74] Michael Karin,et al. Nod2 Mutation in Crohn's Disease Potentiates NF-κB Activity and IL-1ß Processing , 2005, Science.
[75] P. Lécine,et al. A role for Erbin in the regulation of Nod2-dependent NF-kappaB signaling. , 2005, The Journal of biological chemistry.
[76] L. Cantley,et al. The Crohn's Disease Protein, NOD2, Requires RIP2 in Order to Induce Ubiquitinylation of a Novel Site on NEMO , 2004, Current Biology.
[77] M Schwab,et al. NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression , 2004, Gut.
[78] Tomohiro Watanabe,et al. NOD2 is a negative regulator of Toll-like receptor 2–mediated T helper type 1 responses , 2004, Nature Immunology.
[79] G. Rogler,et al. Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation. , 2004, Blood.
[80] Judy H. Cho,et al. Expression of NOD2 in Paneth cells: a possible link to Crohn’s ileitis , 2003, Gut.
[81] Charles A. Janeway,et al. IRAK-M Is a Negative Regulator of Toll-like Receptor Signaling , 2002, Cell.